Last reviewed · How we verify
NCT07412548: AR-MHD
Autogenic Relaxation and Murottal Therapy in Hemodialysis Patients
NA trial testing Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy in Chronic Kidney Disease Stage V in 76 participants. Not yet recruiting.
31 May 2026
Quick facts
| Lead sponsor | Universitas Muhammadiyah Surakarta |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 76 |
| Start date | 1 March 2026 |
| Primary completion | 31 May 2026 |
| Estimated completion | 30 June 2026 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy
- listening to dangdut music
Conditions studied
- Chronic Kidney Disease Stage V — all drugs for Chronic Kidney Disease Stage V →
- End-Stage Renal Disease — all drugs for End-Stage Renal Disease →
- Hemodialysis — all drugs for Hemodialysis →
Sponsor
Universitas Muhammadiyah Surakarta
Who can join
Adults 18 to 65, any sex, with Chronic Kidney Disease Stage V or End-Stage Renal Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This quasi-experimental study aims to evaluate the effect of combined autogenic relaxation and Surah Ar-Rahman murottal therapy on anxiety, sleep quality, and hemodynamic parameters in hemodialysis patients. A pretest-posttest control group design will be used involving 76 participants undergoing routine hemodialysis. Participants will be assigned to an intervention group receiving structured autogenic relaxation followed by murottal therapy and a control group receiving standard care with music listening. Anxiety, sleep quality, and hemodynamic parameters will be measured at baseline and after a 6-week intervention period. The findings are expected to support the use of non-pharmacological and spiritual-based interventions in improving psychological and physiological outcomes in hemodialysis patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07412548
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Kidney Disease Stage V
Currently open trials in the same condition.
- NCT06611189 — A Comparative Analysis of Ray-Tech Sponge and Ice Bag Techniques in Kidney Transplantation · active not recruiting
Other Universitas Muhammadiyah Surakarta trials
Trials by the same sponsor.
- NCT07515677 — Digital Discharge Planning to Improve Self-Management in Patients With Diabetes Mellitus · NA · not yet recruiting
- NCT07405593 — Head Up Position and Murottal Therapy in Stroke Patients · NA · not yet recruiting
- NCT07464418 — Effect of Intradialytic Eating Timing on Hemodynamic Stability and Dialysis Adequacy in Hemodialysis Patients · NA · completed
- NCT07302178 — Combined Bitter Melon Extract and Snakehead Fish Powder Supplementation for Glycemic Control in Type 2 Diabetes · NA · not yet recruiting
- NCT07378748 — Effect of Bedtime Mindfulness Meditation on Anxiety and Spiritual Well-Being in Hemodialysis Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07412548 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitas Muhammadiyah Surakarta
- Last refreshed: 17 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07412548.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing